Fatal interstitial lung disease associated with icotinib

The most serious, and maybe fatal, yet rare, adverse reaction of gefitinib and erlotinib is drug-associated interstitial lung disease (ILD), which has been often described. However, it has been less well described for icotinib, a similar orally small-molecule tyrosine kinase inhibitor (TKI). The cas...

Full description

Saved in:
Bibliographic Details
Published in:J Thorac Dis
Main Authors: Zhang, Jiexia, Zhan, Yangqing, Ouyang, Ming, Qin, Yinyin, Zhou, Chengzhi, Chen, Rongchang
Format: Artigo
Language:Inglês
Published: Pioneer Bioscience Publishing Company 2014
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4283337/
https://ncbi.nlm.nih.gov/pubmed/25590006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2014.10.24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items